Skip to main content
Premium Trial:

Request an Annual Quote

Exagen Receives CAP Accreditation

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Molecular diagnostics laboratory Exagen Diagnostics today announced it has received accreditation from the College of American Pathologists.

As a result, Exagen becomes one of more than 17,000 CAP-accredited labs around the world. Based in Albuquerque, N.M., Exagen develops and markets genomic tests.

"As we continue to develop new genomic tests independently and through partnerships with pharmaceutical and diagnostics companies, having CAP accreditation validates our position as one of the world's most forward-looking laboratories," said Exagen Clinical Laboratory Director John Hozier, said in a statement.

CAP accreditation is based on an on-site inspection of the laboratory's records and quality-control procedures for the preceding two years, laboratory staff qualifications, and laboratory equipment, among other things.

The Scan

Steps for Quick Review

The US Food and Drug Administration is preparing for the quick review of drugs and vaccines for the Omicron variant, according to the Wall Street Journal.

Moving Away From Using Term 'Race'

A new analysis finds that geneticists are using the term "race" in their papers less than in years past, as Science reports.

Point of the Program

The Guardian writes that some scientists have called the design of a UK newborn sequencing program into question.

Science Papers Present Multi-Omic Analysis of Lung Cells, Regulation of Cardiomyocyte Proliferation

In Science this week: a multi-omic analysis of lung cells focuses on RIT1-regulated pathways, and more.